Expanding hemophilia care in developing countries

Seminars in Thrombosis and Hemostasis

Volumn 31, Issue 5, 2005, Pages 561-568

  O'Mahony, Brian ^a   Black, Claudia ^b  

^a IRISH HAEMOPHILIA SOCIETY   (Ireland)

^b WORLD FEDERATION OF HEMOPHILIA   (Canada)

Author keywords

Educational programs; Hemophilia; Outreach programs; Treatment centers; World Federation of Haemophilia

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE;

BLOOD BANK; CLINICAL PRACTICE; DEVELOPING COUNTRY; EDUCATION PROGRAM; GOVERNMENT; HEMOPHILIA; HUMAN; LABORATORY DIAGNOSIS; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RARE DISEASE; REVIEW; TREATMENT OUTCOME;

DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH OCCUPATIONS; HEMOPHILIA A; HUMANS;

EID: 27844482093     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-922228     Document Type: Review

References (25)

1. O'Mahony B. Global haemophilia care: challenges and opportunities. Lecture presented at: XXV International Congress of the WFH; May 20, 2002; Seville, Spain
2. Anonymous. WFH Global Survey Data 2002. Montreal: WFH; 2002
3. Evatt B. Observations from Global Survey 2001: an emerging database for progress. Haemophilia 2002;8:153-156
4. Srivastava A, Chuansumrit A, Chandy M, Duraisamy G, Karabus C. Management of haemophilia in the developing world. Haemophilia 1998;4:474-480
5. Globe D, Cunningham W, Andersen R, et al. The Haemophilia Utilization Group Study: Cost of out-patient, inpatient and pharmaceutical care. Int J Fed Oncol Hematol 2001;7:87-100
6. Anonymous. Guidelines for the Development of a National Programme for Haemophilia, 1996. Geneva, Switzerland: WFH/WHO; 1996
7. Evatt BL, Robillard L. Establishing haemophilia care in developing countries: using data to overcome the barrier of pessimism. Haemophilia 2000;6:131-134
8. Rickard K. The International Hemophilia Training Centres of the World Federation of Hemophilia: a 30-year review. Haemophilia 2000;6:471-473
9. Anonymous. Improving Care Beyond Our Borders: A Twinning Guide for Hemophilia Treatment Centres. Montreal: WFH; 2002
10. Anonymous. Haemophilia in Pictures. Montreal: WFH; 1996
11. Anonymous. Diagnosis of Haemophilia and Other Bleeding Disorders: A Laboratory Manual. Montreal: WFH; 2000
12. Anonymous. Key Issues in Haemophilia Treatment. Part 1: Products. Part 2: Organizing a National Programme for Comprehensive Haemophilia Care. Monograph: Facts and Figures 1. Montreal: WFH; 1998
13. Lloyd S. The Preparation of Single Donor Cryoprecipitate. Monograph: Facts and Figures 2. Montreal: WFH; 1997
14. Petersen IP, Bird AR. Small Pool Heat Treated Intermediate Purity Factor VII Concentrate. Monograph: Facts and Figures 3. Montreal: WFH; 1997
15. Teitel J. Viral Safety of Coagulation Factor Concentrates. Monograph: Facts and Figures 4. Montreal: WFH; 1997
16. Contract Fractionation. Monograph: Facts and Figures 5. Montreal: WFH; 1998
17. Kasper CK, Costa e Silva M. Registry of Clotting Factor Concentrates. Monograph: Facts and Figures 6. Montreal: WFH; 2000
18. Teitel J. Transmissible Agents and the Safety of Coagulation Factor Concentrates. Monograph: Facts and Figures 7 (replaces #4). Montreal: WFH; 1999
19. Proceedings of WFH precongress symposium on Blood Component Therapy. Bangkok, Thailand; October 24, 1999; Montreal: WFH
20. O'Mahony B. Haemophilia Societies: Challenges and Development, WFH Monograph, January 2000. Montreal: WFH; 2000
21. Anonymous. Reaching Beyond Our Borders - A Twinning Guide for Haemophilia Organizations. Montreal: WFH; 2001
22. Isarangkura P. Haemophilia care in the developing world: benchmarking for excellence. Haemophilia 2002;8:205-210
23. Evatt BL, Austin H, Leon G, Ruiz-Saez A, De Bosch N. Haemophilia therapy: assessing the cumulative risk of HIV exposure by cryoprecipitate. Haemophilia 1999;5:295-300
24. WFH/WHO recommendations, June 1997. Haemophilia 1998;4(suppl 2):64-66
25. Delivery of Treatment for Haemophilia. Report of a joint WHO/WFH/ISTH Meeting; February 11-13, 2002; WHO Human Genetics Programme; London, United Kingdom; 2002